The Iceland-founded biopharmaceutical company Oculis which is purposefully driven to save sight and improve eye care with innovations has raised $15M as first reported by Viðskiptablaðið. The participating investors in this newly secured funding round are from Iceland and abroad. This funding adds to the $80M that the company raised in October last year. Along … Continue reading Oculis raises an additional $15M in funding before going public